CAPITOL SOLUTIONS for AMGEN USA
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS New | N/A |
| DANIEL C TATE New | N/A |
Medicare/Medicaid MMM
Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS New | N/A |
| DANIEL C TATE New | N/A |
Health Issues HCR
Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS New | N/A |
| DANIEL C TATE New | N/A |
Budget/Appropriations BUD
Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS New | N/A |
| DANIEL C TATE New | N/A |
Food Industry (safety, labeling, etc.) FOO
Medicare Part B/D reimbursement, FDA follow-on biologics, intellectual property regarding pharmaceutical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CURTIS New | N/A |
| DANIEL C TATE New | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.